SCHEMBL18824719

SCHEMBL18824719

Cn1c(=O)[nH]c2c3cc(Br)c(F)cc3nc(C3CCOCC3)c21

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ CSNK2A2 P19784 1/20 0.33
▸ CSNK2B P67870 1/20 0.33
▸ CSNK2A1 P68400 1/20 0.33
▸ BRD4 O60885 3/20 0.33
▸ CREBBP Q92793 3/20 0.33
▸ PDE1B Q01064 1/20 0.32
▸ YTHDF2 Q9Y5A9 1/20 0.32
▸ PARP14 Q460N5 2/20 0.31
▸ KCNH2 Q12809 2/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ CHRM4 P08173 1/20 0.31
▸ CHRM5 P08912 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ CHRM3 P20309 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17241477 0.88 TLR7 (0.32) IRAK4CSNK2A2CSNK2BCSNK2A1KCNH2
SCHEMBL18824621 0.88 TLR7 (0.32) IRAK4CSNK2A2CSNK2BCSNK2A1KCNH2
SCHEMBL17241473 0.83 CASP3 (0.36) CSNK2A2CSNK2BCSNK2A1BRD4CREBBP
SCHEMBL17241431 0.82 PIK3CA (0.33) KCNH2PIK3CAATM
SCHEMBL18824735 0.82 ATM (0.42) KCNH2PIK3CAATM
SCHEMBL17241384 0.81 ATM (0.45) KCNH2PIK3CAATM
SCHEMBL17241645 0.79 CSNK2A2 (0.33) CSNK2A2CSNK2BCSNK2A1PIK3CAATM
SCHEMBL17241436 0.77 ATM (0.41) BRD4KCNH2PIK3CAATM
SCHEMBL18824763 0.76 ATM (0.47) KCNH2PIK3CAATM
SCHEMBL18824627 0.76 ATM (0.51) KCNH2PIK3CAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3371183-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2018-09-12 — — EP disclosed
EP-3370722-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2018-09-12 — — EP disclosed
WO-2017076895-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2017-05-11 — — WO disclosed
WO-2017076898-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2017-05-11 — — WO disclosed
Send feedback